BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6803562)

  • 1. Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin.
    Wenting GJ; de Bruyn JH; Man in't Veld AJ; Woittiez AJ; Derkx FH; Schalekamp MA
    Am J Cardiol; 1982 Apr; 49(6):1453-9. PubMed ID: 6803562
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension.
    Aldigier JC; Plouin PF; Guyene TT; Thibonnier M; Corvol P; Menard J
    Am J Cardiol; 1982 Apr; 49(6):1447-52. PubMed ID: 7041584
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.
    Havelka J; Vetter H; Studer A; Greminger P; Lüscher T; Wollnik S; Siegenthaler W; Vetter W
    Am J Cardiol; 1982 Apr; 49(6):1467-74. PubMed ID: 6280477
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term efficacy of captopril in renovascular and essential hypertension.
    Case DB; Atlas SA; Marion RM; Laragh JH
    Am J Cardiol; 1982 Apr; 49(6):1440-6. PubMed ID: 6803561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active and inactive renin after a single dose of captopril in hypertensive patients.
    Glorioso N; Dessi Fulgheri P; Madeddu P; Fois G; Palermo M; Cocco F; Dettori S; Rappelli A
    Am J Cardiol; 1982 Apr; 49(6):1552-4. PubMed ID: 7041596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Captopril in renal artery stenoses and renal insufficiency].
    Kirchertz EJ; Scheler F
    Internist (Berl); 1982 Apr; 23(4):237-40. PubMed ID: 7045027
    [No Abstract]   [Full Text] [Related]  

  • 7. Captopril in the management of hypertension with renal artery stenosis: its long-term effect as a predictor of surgical outcome.
    Atkinson AB; Brown JJ; Cumming AM; Fraser R; Lever AF; Leckie BJ; Morton JJ; Robertson JI; Davies DL
    Am J Cardiol; 1982 Apr; 49(6):1460-6. PubMed ID: 7041585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Captopril in the clinical treatment of renovascular hypertension].
    Ribeiro AB; Alves Filho G; de Almeida FA; Kohlmann Junior O; Stella SR; Ramos OL
    AMB Rev Assoc Med Bras; 1980 May; 26(5):153-6. PubMed ID: 7005991
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute and chronic systemic and pulmonary hemodynamic effects of angiotensin converting enzyme inhibition with captopril in hypertensive patients.
    Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L
    Am J Cardiol; 1980 Aug; 46(2):295-300. PubMed ID: 6250392
    [No Abstract]   [Full Text] [Related]  

  • 10. Captopril affects blood pressure equally in renovascular and essential hypertension and in the fluid-depleted anephric state.
    de Bruyn JH; Wenting GJ; Man in 'T Veld AJ; Derkx FH; Schalekamp MA
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():83s-86s. PubMed ID: 7004742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
    Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
    Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
    [No Abstract]   [Full Text] [Related]  

  • 12. Increase in plasma aldosterone during prolonged captopril treatment.
    Lijnen P; Staessen J; Fagard R; Amery A
    Am J Cardiol; 1982 Apr; 49(6):1561-3. PubMed ID: 7041598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA; Drayer JI; Priest RT; Chen TC
    Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of captopril on renal hemodynamics in the treatment of resistant renal hypertension.
    Björck S; Herlitz H; Nyberg G; Granerus G; Aurell M
    Hypertension; 1983; 5(5 Pt 2):III152-3. PubMed ID: 6354931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Captopril - profile of a new antihypertensive (author's transl)].
    Gross F
    MMW Munch Med Wochenschr; 1981 Nov; 123(47):1803-9. PubMed ID: 6796855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril in the treatment of clinical hypertension and cardiac failure.
    Atkinson AB; Robertson JI
    Lancet; 1979 Oct; 2(8147):836-9. PubMed ID: 90928
    [No Abstract]   [Full Text] [Related]  

  • 17. Exaggerated response of renin secretion to captopril (SQ 14225) in renovascular hypertension.
    Imai Y; Abe K; Otsuka Y; Sakurai Y; Ito T; Sato M; Haruyama T; Omata K; Hiwatari M; Yoshinaga K
    Jpn Heart J; 1980 Nov; 21(6):793-802. PubMed ID: 7007685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effects of captopril and saralasin in essential and renal hypertension.
    Konrads A; Meurer KA; Hummerich W; Wambach G; Kindler J; Feltkamp H; Helber A
    Am J Cardiol; 1982 Apr; 49(6):1558-60. PubMed ID: 7041597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of captopril in arterial hypertension with a stable and malignant course].
    Lordkipanidze NL
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):111-7. PubMed ID: 6145432
    [No Abstract]   [Full Text] [Related]  

  • 20. Captopril in treatment-resistant essential and renal hypertension.
    Aurell M; Delin K; Herlitz H
    Scand J Urol Nephrol; 1982; 16(3):243-9. PubMed ID: 6761860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.